Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

MANG - SoftOx Solutions AS: SoftOx Solutions AS appoints Dr. Tore Duvold as new board member

Company: SoftOx Solutions AS Date: 2025-06-27 Language: English Register to download

Loading document preview...

Document Preview Not Available

The file type (.html) cannot be displayed directly here.

Open Original File

Error loading document preview. Please try the 'Open Original File' link.

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method:

Continue with Google Continue with Microsoft Continue with Facebook Continue with Amazon

 SoftOx Solutions AS: SoftOx Solutions AS appoints Dr. Tore Duvold as new board member

# SoftOx Solutions AS: SoftOx Solutions AS appoints Dr. Tore Duvold as new board member

At its Annual General Meeting, SoftOx AS is pleased to announce the election of Dr. Tore Duvold as a new member of the Board of Directors.  

  

Dr. Duvold brings over 25 years of experience in the life science sector, including leadership roles in biotech, pharma, and public innovation funding. He currently serves as CEO of the Swedish diagnostics company Spermosens AB and has held senior positions at LEO Pharma, Aker Biopharma AS, Innovation Fund Denmark, Edvince AB, and Coegin Pharma. In addition, he has served on the board of Medicon Valley Alliance and been involved in several board roles.  

  

"SoftOx’s technology platform has strong potential to address major global health challenges related to infection and antimicrobial resistance," said Dr. Tore Duvold. "I look forward to contributing to the company’s development and value creation in the coming years."  

  

Ulrik Spork, Chairman of the Board, welcomed the appointment:  

"We are very pleased to have Tore join the board. His deep sector knowledge and experience in driving innovation and partnerships will strengthen SoftOx as we continue to advance our strategy and position the company for future growth."  

  

For further information, please contact:  

Ulrik Spork, COB Soft Solutions AS, +45 31 38 83 87  

Ingrid Juven, CFO SoftOx Solutions AS, +47 918 76 165  

Mail: ir@soft-ox.com  

  

About SoftOx Solutions AS:  

SoftOx Solutions AS (ticker: SOFTX) is a clinical-stage pharmaceutical company listed on Euronext Growth Oslo. The company is developing highly effective pan-antimicrobial pharmaceuticals targeting bacteria, viruses, and fungi. The technology is based on extensive research and development in partnership with leading Nordic research institutes.